Wednesday Sep 17, 2008 (foodconsumer.org) – Early studies
suggest that bisphenol A or BPA may damage the brain, reproductive system and
immune system.
A new observation study
now suggests that the chemical may raise risk of heart disease, diabetes and
liver malfunctions, two major diseases that plague developed countries.
BPA, widely used in everyday plastics including baby bottles,
food containers and epoxy resins used in canned food was present at much higher
levels in people with heart diseases, diabetes and liver abnormalities, the
study found.
For the study, published Tuesday in the Journal of the American
Medical Association, researchers from the UK and the University of Iowa went
through the data on the BPA level in the urine samples from 1,455 men and women
and found the disturbing associations.
The researchers found those in the quartile with the
highest levels of BPA were three times as likely to have cardiovascular disease
and 2.4 times as likely to have diabetes as those in the quartile with the
lowest level. Those with highest levels were also found at higher risk of abnormal
levels of three liver enzymes.
The study was not a trial and did not reveal a causal
relationship between high levels of BPA and high risk of heart disease and
diabetes, meaning that BPA does not necessarily cause the diseases. The
industry has long maintained that there is no significant concern about the
safety of bisphenol A.
Regardless, a health observer who does not want to be
named said the study still points to the possibility that BPA may have
something to do with the increased risk of heart disease and diabetes.
Some early studies have already indicated
that such a possibility is more likely than not.
BPA is known as an endocrine disruptor.
An early study has found that BPA exerted
rapid effects on insulin releasing beta-cells and glucagon releasing alpha-cells
within freshly isolated endocrine cells of the pancreas after a short time of
exposure.
The study showed male mice rapidly increased blood
insulin and decreased glycaemia when exposed to 10 mcg/kg of BPA. At the dose
of 100 mcg/kg/day for 4 days, the environmental estrogen resulted in an
increase in beta-cell insulin along with postprandial hyperinsulinaemia and
insulin resistance.
The study was conducted by Ropero AB and colleagues from
Universidad Miguel Hernández de Elche in Alicante, Spain and published in the
April 2008 issue of International Journal of Andrology.
The U.S. Environmental Protection Agency sets the
reference dosage of bisphenol A, which is believed to be safe, at 50
mcg/kg/day. The results of this study suggest that BPA at a level lower than
the EPA standard may potentially boost the risk of developing type 2 diabetes
in humans.
Another study conducted by Alonso-Magdalena P and
colleagues also from Universidad Miguel Hernández de Elche, Alicante, Spain and
published in the Jan 2006 issue of Environmental Health Perspectives showed the
toxic effect of BPA starts at the level of 10 mcg/kg.
The researchers found 2 days after treated with 10 mcg of
BPA/kg of body weight/day, mice experienced an increase in pancreatic beta-cell
insulin content.
After 4 days of the
treatment, "the mice developed chronic hyperinsulinemia, and their glucose
and insulin tolerance tests were altered," the authors wrote.
A most recent study published online in Environmental
Health Perspectives on August 14, which was reported by foodconsumer.org on Sep
1, 2008, found bisphenol A at the level found commonly found in humans' blood
can suppress a hormone that protects people from heart attacks and type 2
diabetes.
The study led by Nira Ben-Jonathan, an endocrinologist at
the University of Cincinnati in Ohio showed the level of adiponectin, a
protective hormone released by human breast fat cells, decreased after exposure
to bisphenol A. The effective levels of the chemical were commonly found in
human blood.
In the study, the researchers exposed some human cells to
estradiol, a natural human estrogen and some to bisphenol A.
Both groups of cells released reduced
amounts of the protective hormone adiponectin, which protects against heart
attacks and type 2 diabetes.
Early on Sep 3, the National Toxicology Program released
a final report on bisphenol A saying that the current human exposure to this
chemical is of "some concern for its effect on development of the prostate
gland and brain and fetuses, infants and children. But the government agency
does not recognize the potential impact of BPA on the heart disease and diabetes
risk.
The Food and Drug Administration said early and said
again at the time of releasing the new study that bisphenol A poses no risk at
the current level of exposure, but only acknowledged that further studies are
needed.
Sen. Charles Grassley, R-Iowa and some of his Democratic
colleagues are reportedly looking into whether the FDA opinion has been unduly influenced
by the chemical industry, news media reports.
Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only.
The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals.
Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.